Status:
COMPLETED
Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients
Lead Sponsor:
GlaxoSmithKline
Conditions:
Varicella
Eligibility:
All Genders
1-16 years
Phase:
PHASE3
Brief Summary
This study is conducted in order to collect clinical samples from patients who are diagnosed of having chickenpox infection. The results of this study will provide basic scientific information about c...
Detailed Description
The study involves NO therapeutic or prophylactic treatment nor further observation of the patients. There is no product to be tested in this study.
Eligibility Criteria
Inclusion
- Pediatric patients who are diagnosed of having varicella and are presenting varicella dermal lesions.
Exclusion
Key Trial Info
Start Date :
June 7 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 13 2006
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00127608
Start Date
June 7 2005
End Date
July 13 2006
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Prague, Czechia, 180 81